← Back to Search

Behavioral Intervention

Sensory Intervention for Dementia (EASE Trial)

N/A
Recruiting
Led By Justine S Sefcik
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Residents must have a medical diagnosis of dementia
Residents must be 65 years or older
Must not have
Residents who are blind
Residents who are deaf
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 minutes
Awards & highlights

Summary

This trial aims to test a nature-based intervention for nursing home residents with dementia who frequently vocalize. The intervention, called EASE, involves showing nature images and playing nature sounds to the residents. Family

Who is the study for?
This trial is for nursing home residents with dementia who often make repetitive sounds. Family members must consent and fill out a survey about the resident's nature preferences. The study requires participants to wear a stress-measuring watch.
What is being tested?
The EASE intervention, which includes displaying still nature images and playing nature sounds, is being tested to see if it helps reduce persistent vocalizations in people with dementia.
What are the potential side effects?
Since this is a non-pharmacological intervention involving sensory experiences like visual and auditory stimuli from nature, there are no direct medical side effects expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with dementia.
Select...
I am 65 years old or older.
Select...
I need a lot of help to walk or can't walk at all, making it easy to record me.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am legally blind.
Select...
I am deaf.
Select...
I have never understood English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Persistent Vocalizations (PVs)
Secondary outcome measures
Acceptability of Intervention Measure
Electrodermal Activity
Heart Rate (HR)

Trial Design

1Treatment groups
Experimental Treatment
Group I: EASE InterventionExperimental Treatment1 Intervention
Thirty-two persons with dementia will be exposed by an interventionist to an Environmental And Sensory Experience (EASE) intervention which involves a tailored, person-centered nature scene projected with associated nature sounds. A within-person design will be used where the participants will serve as their own controls and be observed 30 minutes prior to, 30 minutes during, and for 30 minutes directly after EASE.

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
153 Previous Clinical Trials
48,094 Total Patients Enrolled
4 Trials studying Dementia
426 Patients Enrolled for Dementia
National Institute of Nursing Research (NINR)NIH
598 Previous Clinical Trials
10,378,130 Total Patients Enrolled
17 Trials studying Dementia
5,295 Patients Enrolled for Dementia
Justine S SefcikPrincipal InvestigatorDrexel University
~21 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top